市場調査レポート
商品コード
1414094

細胞・遺伝子治療製造サービスの世界市場レポート 2024年

Cell & Gene Therapy Manufacturing Services Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
細胞・遺伝子治療製造サービスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

細胞・遺伝子治療製造サービスの市場規模は近年急速に拡大しています。2023年の72億5,000万米ドルから2024年には85億5,000万米ドルへと、CAGR17.8%で拡大します。前期に見られた成長は、いくつかの重要な要因によるものです。これには、研究開発(R&D)イニシアティブへの投資の増加、細胞・遺伝子治療の進歩を促進する支持的な規制の枠組み、細胞・遺伝子治療製品の急増するパイプライン、イノベーションを促進する業界内の共同研究やパートナーシップ、個別化医療ソリューションに対する世界の需要の高まりなどが含まれます。これらの要因が、この期間に細胞・遺伝子治療分野で見られた成長の総体的な要因となりました。

北米は、2023年の細胞・遺伝子治療製造サービス市場において最大の地域でした。アジア太平洋は、世界の細胞・遺伝子治療製造サービス市場レポート予測期間で最も急成長している地域になると予想されています。細胞・遺伝子治療製造サービス市場レポート対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の細胞・遺伝子治療製造サービス市場、タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 遺伝子治療
  • 細胞治療
  • 世界の細胞・遺伝子治療製造サービス市場、適応症別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 中枢神経系疾患
  • 眼科疾患
  • 心血管疾患
  • 感染症
  • 整形外科疾患
  • 腫瘍疾患
  • 世界の細胞・遺伝子治療製造サービス市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 商業製造
  • 臨床製造
  • 世界の細胞・遺伝子治療製造サービス市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 学術・研究機関
  • 製薬企業・バイオテクノロジー企業
  • その他

第7章 地域および国の分析

  • 世界の細胞・遺伝子治療製造サービス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の細胞・遺伝子治療製造サービス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 細胞・遺伝子治療製造サービス市場の競合情勢
  • 細胞・遺伝子治療製造サービス市場の企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Charles River Laboratories International Inc.
    • Lonza Group AG
    • Catalent Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11604

“Cell & Gene Therapy Manufacturing Services Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell & gene therapy manufacturing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell & gene therapy manufacturing services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cell & gene therapy manufacturing services market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Gene Therapy; Cell Therapy
  • 2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
  • 3) By Application: Commercial Manufacturing; Clinical Manufacturing
  • 4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Charles River Laboratories International Inc.; Lonza Group AG; Catalent Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cell and gene therapy manufacturing services encompass processes dedicated to manufacturing and ensuring the quality of gene and cell therapy products. These services play a pivotal role in developing treatments for degenerative conditions, tissue injuries, and genetic abnormalities. They involve adhering to good manufacturing practices, utilizing ancillary reagents, conducting flow cytometry and immunoassays, and offering gene engineering services.

The primary types of these manufacturing services include gene therapy and cell therapy. Gene therapy involves addressing underlying genetic issues to treat or prevent diseases. These services cater to both commercial manufacturing and clinical applications, targeting diverse medical indications such as central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopedic diseases, and oncology diseases. These specialized services are utilized by academic and research institutes, pharmaceutical and biotechnology companies, and other relevant entities involved in the development and production of cell and gene therapies aimed at addressing various medical conditions.

The cell and gene therapy manufacturing services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy manufacturing services optical components market statistics, including cell and gene therapy manufacturing services optical components industry global market size, regional shares, competitors with a cell and gene therapy manufacturing services optical components market share, detailed cell and gene therapy manufacturing services optical components market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy manufacturing services optical components industry. This cell and gene therapy manufacturing services optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from $7.25 billion in 2023 to $8.55 billion in 2024 at a compound annual growth rate (CAGR) of 17.8%. The growth observed in the previous period can be attributed to several key factors. These include heightened investments in research and development (R&D) initiatives, supportive regulatory frameworks facilitating advancements in cell and gene therapies, a burgeoning pipeline of cell and gene therapy products, collaborations and partnerships within the industry fostering innovation, and a rising global demand for personalized medicine solutions. These factors collectively contributed to the growth witnessed in the field of cell and gene therapies during that timeframe.

The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $15.77 billion in 2028 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability.

The cell and gene therapy manufacturing services market is anticipated to experience growth due to the increasing prevalence of diseases such as cancer. Cancer's rapid and uncontrolled cell growth has led to a surge in demand for more effective treatments, spurring the development of cell and gene therapies. For example, in January 2023, the American Cancer Society reported a 3.16% increase in cancer cases from 2021 to 2023, highlighting the escalating need for innovative therapies to address this trend.

The market for cell and gene therapy manufacturing services is expected to expand further owing to the rising adoption of personalized medicine. This approach tailors medical treatments to individual patient characteristics, significantly enhancing the efficacy of cell and gene therapies. Notably, in January 2023, the FDA's Center for Drug Evaluation and Research approved 37 new molecular entities in 2022, with 12 of them classified as personalized medicines by the Personalized Medicine Coalition (PMC), signifying the growing prominence of personalized treatments.

Technological advancements are driving trends in the cell and gene therapy manufacturing services market. Companies are embracing innovative technologies to maintain their market positions. For instance, in October 2022, Charles River Laboratories International Inc. introduced the navigation Vector Platform, simplifying GMP Adeno-Associated Virus (AAV) vector manufacturing. This platform drastically reduces the time required for viral vector gene therapy researchers compared to conventional workflows, enhancing efficiency and scalability.

Collaborations and partnerships among key players are reshaping the cell and gene therapy manufacturing services market, fostering innovation and accelerating product development. An instance is the collaboration between Allogene Therapeutics Inc. and Antion Biosciences SA to advance multiplex gene silencing for developing next-generation allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.

In January 2021, Thermo Fisher Scientific Inc., a US-based provider of scientific instrumentation, reagents, consumables, and software services, acquired Henogen SA for $880 million in cash. The acquisition would expand Thermo Fisher's global capacity for cell and gene therapies. In the viral vector sector, it continues enhancing its capabilities for cell and gene vaccines and therapeutics globally. The laboratory products and services division of Henogens would be integrated into Thermo Fisher's Pharma Services business. Henogen SA is a Belgium-based biomanufacturing company with development and manufacturing services.

Major companies operating in the cell & gene therapy manufacturing services market report are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd., Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

North America was the largest region in the cell and gene therapy manufacturing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell & gene therapy manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Cell & Gene Therapy Manufacturing Services Market Characteristics

3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies

4. Cell & Gene Therapy Manufacturing Services Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Cell & Gene Therapy Manufacturing Services Market Size and Growth

  • 5.1. Global Cell & Gene Therapy Manufacturing Services Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell & Gene Therapy Manufacturing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell & Gene Therapy Manufacturing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell & Gene Therapy Manufacturing Services Market Segmentation

  • 6.1. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gene Therapy
  • Cell Therapy
  • 6.2. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Central Nervous System Disorders
  • Ophthalmology Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Orthopedic Diseases
  • Oncology Diseases
  • 6.3. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Commercial Manufacturing
  • Clinical Manufacturing
  • 6.4. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users

7. Cell & Gene Therapy Manufacturing Services Market Regional And Country Analysis

  • 7.1. Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

  • 8.1. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell & Gene Therapy Manufacturing Services Market

  • 9.1. China Cell & Gene Therapy Manufacturing Services Market Overview
  • 9.2. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell & Gene Therapy Manufacturing Services Market

  • 10.1. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell & Gene Therapy Manufacturing Services Market

  • 11.1. Japan Cell & Gene Therapy Manufacturing Services Market Overview
  • 11.2. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell & Gene Therapy Manufacturing Services Market

  • 12.1. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell & Gene Therapy Manufacturing Services Market

  • 13.1. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell & Gene Therapy Manufacturing Services Market

  • 14.1. South Korea Cell & Gene Therapy Manufacturing Services Market Overview
  • 14.2. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell & Gene Therapy Manufacturing Services Market

  • 15.1. Western Europe Cell & Gene Therapy Manufacturing Services Market Overview
  • 15.2. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell & Gene Therapy Manufacturing Services Market

  • 16.1. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell & Gene Therapy Manufacturing Services Market

  • 17.1. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell & Gene Therapy Manufacturing Services Market

  • 18.1. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell & Gene Therapy Manufacturing Services Market

  • 19.1. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell & Gene Therapy Manufacturing Services Market

  • 20.1. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell & Gene Therapy Manufacturing Services Market

  • 21.1. Eastern Europe Cell & Gene Therapy Manufacturing Services Market Overview
  • 21.2. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell & Gene Therapy Manufacturing Services Market

  • 22.1. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell & Gene Therapy Manufacturing Services Market

  • 23.1. North America Cell & Gene Therapy Manufacturing Services Market Overview
  • 23.2. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell & Gene Therapy Manufacturing Services Market

  • 24.1. USA Cell & Gene Therapy Manufacturing Services Market Overview
  • 24.2. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell & Gene Therapy Manufacturing Services Market

  • 25.1. Canada Cell & Gene Therapy Manufacturing Services Market Overview
  • 25.2. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell & Gene Therapy Manufacturing Services Market

  • 26.1. South America Cell & Gene Therapy Manufacturing Services Market Overview
  • 26.2. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell & Gene Therapy Manufacturing Services Market

  • 27.1. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell & Gene Therapy Manufacturing Services Market

  • 28.1. Middle East Cell & Gene Therapy Manufacturing Services Market Overview
  • 28.2. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell & Gene Therapy Manufacturing Services Market

  • 29.1. Africa Cell & Gene Therapy Manufacturing Services Market Overview
  • 29.2. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape And Company Profiles

  • 30.1. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape
  • 30.2. Cell & Gene Therapy Manufacturing Services Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Charles River Laboratories International Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lonza Group AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Catalent Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Cell & Gene Therapy Manufacturing Services Market Competitive Benchmarking

32. Global Cell & Gene Therapy Manufacturing Services Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market

34. Cell & Gene Therapy Manufacturing Services Market Future Outlook and Potential Analysis

  • 34.1 Cell & Gene Therapy Manufacturing Services Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Cell & Gene Therapy Manufacturing Services Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Cell & Gene Therapy Manufacturing Services Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer